Search
for
Sort by
Research 30 of 196
- Hair graying and loss induced by imatinib mesylate
- Cutaneous Scarring: Basic Science, Current Treatments, and Future Directions
- Author reply
- Skin manifestations of chronic kidney disease
- Targeted therapy in melanoma
- Cutaneous Drug Reaction Case Reports
- Imatinib-induced classical lichen planopilaris in blaschko-linear distribution leading to cicatricial alopecia
- Keratosis Pilaris-like Eruption during Treatment of Chronic Myeloid Leukemia with Tyrosine Kinase Inhibitors: Literature Review and Report of a Case Related to Imatinib
- The PDGF/PDGFR pathway as a drug target
- Tumour regression predicts higher risk of sentinel node involvement in thin cutaneous melanomas
- Tyrosine kinase inhibition and grey hair
- Medication-Induced Repigmentation of Gray Hair: A Systematic Review
- Repigmentation and new growth of hairs after anti–interleukin-17 therapy with secukinumab for psoriasis
- Hair Re-Pigmentation After Nilotinib
- Sorafenib-induced Facial Acneiform Eruption
- Activity of Sorafenib against Desmoid Tumor/Deep Fibromatosis
- Hierarchical patterning modes orchestrate hair follicle morphogenesis
- Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer
- Adverse effects of common medications on male fertility
- Hair Depigmentation Is a Biological Readout for Pharmacological Inhibition of KIT in Mice and Humans
- Hair disorders in patients with cancer
- Advances in the Management of Cutaneous Toxicities of Targeted Therapies
- Drug Repurposing - Hypothesis, Molecular Aspects and Therapeutic Applications
- Platelet-derived growth factor signaling modulates adult hair follicle dermal stem cell maintenance and self-renewal
- Dormancy in the stem cell niche
- Experimental and thermodynamic analyses of supercritical CO2-Solubility of minoxidil as an antihypertensive drug
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- [4-t-Butylphenyl]-N-(4-imidazol-1-yl phenyl)sulfonamide (ISCK03) inhibits SCF/c-kit signaling in 501mel human melanoma cells and abolishes melanin production in mice and brownish guinea pigs
- Topically used herbal products for the treatment of hair loss: preclinical and clinical studies
- An Update on Drug-Induced Pigmentation